An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Provided herein are novel MALT1 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.
Zhang R.-Y., Wang Z.-X., Zhang M.-Y., Wang Y.-F., Zhou S.-L., Xu J.-L., Lin W.-X., Ji T.-R., Chen Y.-D., Lu T., Li N.-G., Shi Z.-H.. MALT1 inhibitors and degraders: Strategies for NF-KB-driven malignancies. J. Med. Chem. 2025;68:5075–5096. doi: 10.1021/acs.jmedchem.4c02873.
-
DOI
-
PubMed
Brvar, M. ; O’Neill, T. J. ; Plettenburg, O. ; Karppmann, D. . An updated patent review on MALT1 inhibitors (2021-present). Expert Opin. Ther. Pat. 2025, in press. 10.1080/13543776.2025.2484371.
-
DOI
-
PubMed
Yong C., Liang Y., Wang M., Jin W., Fan X., Wang Z., Cao K., Wu T., Li Q., Chang C.. Alternative splicing: A key regulator in T cell response and cancer immunotherapy. Pharmacol. Res. 2025;215:107713. doi: 10.1016/j.phrs.2025.107713.
-
DOI
-
PubMed
Sabnis R. W.. MALT1 inhibitors for treating cancer and immunological diseases. ACS Med. Chem. Lett. 2024;15:1419–1420. doi: 10.1021/acsmedchemlett.4c00390.
-
DOI
-
PMC
-
PubMed
O’Neill T. J., Tofaute M. J., Karppmann D.. Function and targeting of MALT1 paracaspase in cancer. Cancer Treat. Rev. 2023;117:102568. doi: 10.1016/j.ctrv.2023.102568.
-
DOI
-
PubMed